Literature DB >> 32061543

CD38: Modulating Histone Methyltransferase EZH2 Activity in SLE.

Paramita Chakraborty1, Shikhar Mehrotra2.   

Abstract

To keep autoreactive T cells under control in SLE patients, immunosuppressive regimens are used, which can increase susceptibility to bacterial and viral infections. Recently, Katsuyama et al., demonstrated that the CD38/NAD/Sirtuin1/EZH2 axis reduces cytolytic CD8+ T cell function and might be targeted to overcome incidence of infections.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CD38; EZH2; SLE; T cells; methylation

Year:  2020        PMID: 32061543     DOI: 10.1016/j.it.2020.01.008

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  1 in total

Review 1.  The Circular Life of Human CD38: From Basic Science to Clinics and Back.

Authors:  Alberto L Horenstein; Angelo C Faini; Fabio Morandi; Cristiano Bracci; Francesco Lanza; Nicola Giuliani; Aneel Paulus; Fabio Malavasi
Journal:  Molecules       Date:  2020-10-21       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.